Medications for Addiction Treatment (MAT) Service in Colorado & New Mexico

Q: What are the types of Medications for Addiction Treatment?

Medication options including: Buprenorphine/Suboxone, Vivitrol injection, oral naltrexone, Antabuse, Campral, and other options that may be explored based on each individual’s unique needs.

Combining MAT (Medications for Addiction Treatment) and counseling provides a comprehensive approach to addiction recovery.

Get Help Now

Find a Clinic

Primary Item (H2)

Clinically Reviewed By Dr. Jeremy Dubin

What is MAT?

Medication-Assisted Treatment (MAT) is an evidence-based approach to treating substance use disorders. It involves the use of medications, in combination with counseling and behavioral therapies, to help individuals manage addiction. MAT is primarily used for opioid and alcohol use disorders, but it can also be effective for other types of substance use disorders.

The goal of MAT is to not only reduce the cravings and withdrawal symptoms associated with addiction but also to address the underlying causes and behaviors that contribute to substance abuse. By using medication to stabilize brain chemistry and minimize the effects of withdrawal, individuals are better able to engage in community resources and therapy, which can address the psychological and emotional aspects of addiction.

Using MAT for Addiction Treatment

There are several medications approved by the U.S. Food and Drug Administration (FDA) for the treatment of addiction. These medications, when used as part of Medication-Assisted Treatment (MAT), can effectively help individuals reduce or eliminate their substance use while improving their overall well-being.

One commonly used medication for addiction treatment is buprenorphine. Buprenorphine is a partial opioid agonist, meaning it activates the opioid receptors in the brain but to a lesser extent than full agonists like heroin or oxycodone. It helps to reduce cravings and withdrawal symptoms, allowing individuals to focus on their recovery without the intense physical discomfort often associated with opioid withdrawal.

Another medication frequently prescribed for addiction treatment is methadone. Methadone is a full opioid agonist that works by binding to the opioid receptors in the brain, providing relief from withdrawal symptoms and reducing cravings. Methadone is typically administered in a controlled setting, such as a specialized clinic, to ensure safe and effective use. While Methadone is a widely used Medication for Addiction Treatment, Porch Light Health does not prescribe Methadone at this time.

Naltrexone is another medication used in the treatment of addiction. Unlike buprenorphine and methadone, naltrexone is an opioid antagonist, meaning it blocks the effects of opioids in the brain. By blocking the opioid receptors, naltrexone helps to prevent relapse and discourages individuals from using opioids since they will not experience the desired effects.

It is important to note that medication alone is not sufficient for long-term recovery from addiction. Medications used in addiction treatment should always be combined with counseling, therapy, and other support services to address the underlying causes and provide comprehensive care.

MAT with Evidence-Based Therapies

While medications play a crucial role in MAT, they are most effective when combined with counseling and behavioral therapies. Counseling, such as cognitive-behavioral therapy (CBT) and motivational interviewing, can help individuals identify and address the underlying causes of their addiction, develop coping strategies, and learn healthier ways of managing stress and emotions. Behavioral interventions, such as working with a case manager, can also be beneficial in helping individuals establish community resources with housing, food, transportation, etc.

It is important to note that MAT is not a one-size-fits-all approach. The choice of medication and treatment plan should be tailored to the individual's specific needs and circumstances. Regular monitoring and adjustments may be necessary to ensure the effectiveness of the treatment. MAT has been shown to significantly improve outcomes for individuals with substance use disorders, increasing their chances of achieving long-term recovery and improving their overall quality of life.

Medications used for treatment

MAT has gained support and endorsement from various organizations that are at the forefront of addiction treatment and research. Let's take a closer look at some of these influential organizations:

Substance Abuse and Mental Health Services Administration (SAMHSA)

The Substance Abuse and Mental Health Services Administration (SAMHSA) is a branch of the U.S. Department of Health and Human Services. SAMHSA is dedicated to reducing the impact of substance abuse and mental illness on America's communities. They have been strong advocates for MAT, recognizing its effectiveness in improving treatment outcomes and reducing the risk of relapse. SAMHSA provides resources, guidelines, and funding to support the integration of MAT into addiction treatment programs across the country.

American Medical Association (AMA)

The American Medical Association (AMA) is the largest association of physicians and medical students in the United States. They play a crucial role in shaping healthcare policies and practices. The AMA has endorsed MAT as an evidence-based approach to treating substance use disorders. They recognize the importance of providing comprehensive care that includes medications, counseling, and behavioral therapies to address the complex nature of addiction. The AMA's endorsement of MAT has helped raise awareness and promote its integration into mainstream medical practice.

American Society of Addiction Medicine (ASAM)

The American Society of Addiction Medicine (ASAM) is a professional medical society dedicated to improving the treatment of addiction and advancing the field of addiction medicine. ASAM strongly supports MAT as an effective treatment option for individuals with substance use disorders. They provide education, training, and resources to healthcare professionals to enhance their knowledge and skills in delivering MAT. ASAM's endorsement of MAT has been instrumental in increasing its acceptance and utilization within the addiction treatment community.

National Institute on Drug Abuse (NIDA)

The National Institute on Drug Abuse (NIDA) is a federal research institute that focuses on advancing scientific knowledge about drug abuse and addiction. NIDA conducts cutting-edge research and supports studies that contribute to the development of evidence-based treatments. They have recognized MAT as a crucial component of comprehensive addiction treatment. NIDA's endorsement of MAT has helped validate its effectiveness and encourage further research and innovation in this field.

American College of Obstetricians and Gynecologists (ACOG)

The American College of Obstetricians and Gynecologists (ACOG) is a membership organization for obstetrician-gynecologists that promotes guidelines for healthcare professionals. In addition to this, they also provide information for patients, families, and programs around the country. ACOG frequently advocates for women’s health and for its members and patients. They have provided guidelines for using MAT for opioids in pregnant women in need of rehabilitation services.

These organizations, among others, have played a significant role in promoting the adoption and integration of MAT into addiction treatment practices. Their endorsement and support have helped break down barriers and reduce the stigma associated with medication-assisted treatment. As a result, more individuals struggling with substance use disorders can access the comprehensive care they need to achieve lasting recovery.

Medications Used in MAT Services

There are several medications approved by the U.S. Food and Drug Administration (FDA) for the treatment of addiction. These medications, when used as part of Medication-Assisted Treatment (MAT), can effectively help individuals reduce or eliminate their substance use while improving their overall well-being.

One commonly used medication for addiction treatment is buprenorphine. Buprenorphine is a partial opioid agonist, meaning it activates the opioid receptors in the brain but to a lesser extent than full agonists like heroin or oxycodone. It helps to reduce cravings and withdrawal symptoms, allowing individuals to focus on their recovery without the intense physical discomfort often associated with opioid withdrawal.

Naltrexone is another medication used in the treatment of addiction. Unlike buprenorphine and methadone, naltrexone is an opioid antagonist, meaning it blocks the effects of opioids in the brain. By blocking the opioid receptors, naltrexone helps to prevent relapse and discourages individuals from using opioids since they will not experience the desired effects.

It is important to note that medication alone is not sufficient for long-term recovery from addiction. Medications used in addiction treatment should always be combined with counseling, therapy, and other support services to address the underlying causes and provide comprehensive care.

Buprenorphine

Buprenorphine, also known by its brand name of Suboxone®, is a medication commonly used in medication for addiction treatment (MAT) for long-term maintenance therapy of opioid addiction. It is a partial opioid agonist, which means that it activates the same receptors in the brain as other opioids but to a lesser extent. This unique property of buprenorphine helps reduce cravings and withdrawal symptoms without producing the same level of euphoria or sedation as full opioid agonists.

One of the main advantages of buprenorphine is its ability to be prescribed by qualified healthcare providers in an office-based setting, making it more accessible for patients seeking treatment. This convenience eliminates the need for patients to visit specialized clinics or hospitals, allowing them to receive the necessary care in a familiar and comfortable environment.

Buprenorphine can be administered in different forms, providing flexibility in treatment options. The most common forms include tablets, films, and weekly to monthly injections. Tablets are taken orally and dissolve under the tongue, while films are thin strips that also dissolve in the mouth. Implants, on the other hand, are small rods inserted under the skin that release a controlled amount of buprenorphine over a period of time. These different administration methods allow healthcare providers to tailor the treatment to the individual needs and preferences of each patient.

Buprenorphine Treatment Benefits:

Helps reduce cravings and withdrawal symptoms: Buprenorphine's partial agonist activity at opioid receptors helps alleviate the intense cravings and physical discomfort experienced during opioid withdrawal. By binding to these receptors, it provides a sense of relief and stability to individuals in recovery.

Improves treatment retention rates: Compared to other treatment approaches, buprenorphine has shown higher rates of treatment retention. This means that individuals are more likely to remain engaged in their recovery journey, increasing the chances of successful long-term outcomes.

Reduces the risk of overdose and other opioid-related complications: Buprenorphine's unique pharmacological profile reduces the risk of overdose compared to full opioid agonists. Its ceiling effect limits the respiratory depression that can lead to fatal overdoses. Additionally, by stabilizing individuals on buprenorphine, the risk of engaging in high-risk behaviors associated with opioid use, such as needle sharing, is significantly reduced.

Allows individuals to regain stability and functionality in their lives: Buprenorphine treatment not only helps manage the physical aspects of opioid addiction but also provides individuals with the opportunity to rebuild their lives. By reducing cravings and withdrawal symptoms, individuals can focus on their personal and professional goals, repairing relationships, and regaining control over their lives.

Naltrexone (Vivitrol)

Naltrexone, marketed as Vivitrol, is another medication used in MAT for opioid and alcohol use disorders. Unlike buprenorphine, which is an opioid agonist, naltrexone is an opioid antagonist. It works by blocking the opioid receptors in the brain, preventing the effects of opioids and reducing cravings.

Vivitrol, in particular, is administered as a monthly injection, ensuring medication compliance and eliminating the need for daily dosing. This makes it a suitable option for individuals who may struggle with adherence to a daily medication regimen.

Vivitrol Treatment Benefits

Blocks the effects of opioids and reduces cravings.

Eliminates the need for daily medication.

Helps individuals maintain abstinence from opioids or alcohol

Covered by Medicaid

HCP-administered

Porch Light Health is Here to Help

For individuals seeking addiction treatment in Colorado and New Mexico, Porch Light Health offers comprehensive MAT services. Their team of experienced healthcare professionals provides personalized treatment plans that include medication management, counseling, and support for individuals on their recovery journey.

At Porch Light Health, the focus is on providing compassionate, evidence-based care to help individuals break free from the grip of addiction. They understand that each person's journey is unique, and they tailor their treatment approach to meet the specific needs and goals of each individual.

If you or someone you know is struggling with addiction in Colorado or New Mexico, don't hesitate to reach out for help. MAT services, such as those provided by Porch Light Health, can make a significant difference in overcoming addiction and achieving lasting recovery.

Remember, addiction is a chronic treatable medical condition, and with the right support and treatment, individuals can overcome addiction and lead healthy, fulfilling lives. Take that first step towards recovery today.

Frequently Asked Questions

What are the types of Medications for Addiction Treatment?

Medication options including: Buprenorphine/Suboxone®, Vivitrol injection, oral naltrexone, Antabuse, Campral, and other options that may be explored based on each individual’s unique needs.

Do I need medication for my addiction?

Medication gives you the opportunity to “level the playing field” biochemically, so you can create the important psychological, emotional, and social tools necessary to sustain long term recovery. Medications are often necessary to stabilize someone who is going through active addiction. The use of medications speaks to our evolved understanding of the science of addiction- which understands addiction as a chronic relapsing brain disease.

How long should I take the treatment?

Medications can be used short term to long term depending on the needs of the patient. There are no dates our providers put on the duration treatment. Medications are tools that can give the patient an opportunity to create stability. Some patients need medications for a short time while others find a need to use them longer.

866-394-6123

Find The Nearest
Treatment Center

Treatments We Offer

Mobile Sites